X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1123) 1123
male (675) 675
meglumine - pharmacology (639) 639
humans (577) 577
female (506) 506
index medicus (400) 400
meglumine - analogs & derivatives (354) 354
rats (352) 352
pharmacology & pharmacy (318) 318
diatrizoate meglumine - pharmacology (242) 242
contrast media - pharmacology (233) 233
meglumine antimoniate (223) 223
mice (204) 204
dogs (199) 199
adult (192) 192
middle aged (170) 170
organometallic compounds - pharmacology (169) 169
indoles - pharmacology (168) 168
antiprotozoal agents - pharmacology (156) 156
veterinary sciences (156) 156
flunixin meglumine (150) 150
meglumine - therapeutic use (142) 142
contrast media (138) 138
in vitro techniques (125) 125
leishmaniasis (124) 124
receptors, cholecystokinin - antagonists & inhibitors (124) 124
time factors (124) 124
antiprotozoal agents - therapeutic use (122) 122
dose-response relationship, drug (121) 121
visceral leishmaniasis (115) 115
meglumine - administration & dosage (113) 113
cutaneous leishmaniasis (110) 110
osmolar concentration (108) 108
radiology, nuclear medicine & medical imaging (106) 106
parasitology (104) 104
leishmaniasis, cutaneous - drug therapy (101) 101
physiology (101) 101
meglumine (98) 98
organometallic compounds - therapeutic use (97) 97
biochemistry & molecular biology (93) 93
neurosciences (93) 93
cells, cultured (89) 89
aged (88) 88
rats, sprague-dawley (88) 88
adolescent (87) 87
kinetics (84) 84
microbiology (84) 84
research (84) 84
parasitic diseases (83) 83
diatrizoate - pharmacology (81) 81
analysis (80) 80
membrane potentials - drug effects (79) 79
research article (76) 76
pharmacokinetics (75) 75
in-vitro (74) 74
leishmania - drug effects (71) 71
leishmaniasis, visceral - drug therapy (71) 71
rabbits (71) 71
cholecystokinin (69) 69
sodium - metabolism (69) 69
treatment outcome (69) 69
hemodynamics - drug effects (68) 68
hydrogen-ion concentration (68) 68
mice, inbred balb c (68) 68
calcium - metabolism (67) 67
rats, wistar (67) 67
sodium stibogluconate (66) 66
organometallic compounds - administration & dosage (65) 65
drugs (64) 64
iothalamate meglumine - pharmacology (64) 64
cattle (63) 63
patch-clamp techniques (62) 62
blood pressure - drug effects (61) 61
child (61) 61
contrast media - administration & dosage (60) 60
sodium - pharmacology (60) 60
benzodiazepinones - pharmacology (59) 59
diatrizoate - analogs & derivatives (59) 59
antiprotozoal agents - administration & dosage (58) 58
magnetic resonance imaging (58) 58
meglumine - chemistry (58) 58
tropical medicine (57) 57
chemotherapy (56) 56
disease models, animal (56) 56
drug resistance (56) 56
drug combinations (55) 55
horses (54) 54
rats, inbred strains (54) 54
infectious diseases (53) 53
receptor, cholecystokinin b (53) 53
leishmaniasis - drug therapy (52) 52
care and treatment (51) 51
cell line (51) 51
leishmaniasis, cutaneous - parasitology (51) 51
brain (50) 50
efficacy (50) 50
clonixin - analogs & derivatives (49) 49
drug combinations - pharmacology (49) 49
gadolinium (48) 48
cell biology (47) 47
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1584) 1584
Russian (79) 79
German (22) 22
Japanese (11) 11
French (8) 8
Italian (8) 8
Spanish (8) 8
Chinese (5) 5
Polish (4) 4
Czech (3) 3
Portuguese (2) 2
Slovak (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Tropical Medicine and Hygiene, ISSN 0002-9637, 2017, Volume 96, Issue 5, pp. 1143 - 1150
Journal Article
Phytomedicine, ISSN 0944-7113, 07/2014, Volume 21, Issue 8-9, pp. 1048 - 1052
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 07/2006, Volume 214, Issue 2, pp. 166 - 177
Although uranium is a well-characterized nephrotoxic agent, very little is known at the cellular and molecular level about the mechanisms underlying the uptake... 
Sodium-dependent phosphate co-transport | Uranium | NaPi | Cytotoxicity | LLC-PK | MDCK | Uranyl | Speciation | RENAL EPITHELIAL-CELLS | LLC-PK1 | NITRATE | RAT-KIDNEY | uranyl | DOWN-REGULATION | speciation | sodium-dependent phosphate co-transport | INORGANIC ANION-EXCHANGER | PARATHYROID-HORMONE | I-COTRANSPORTER | PHARMACOLOGY & PHARMACY | TOXICOLOGY | uranium | PROXIMAL TUBULE | APICAL MEMBRANE | ADAPTIVE RESPONSE | cytotoxicity | Colchicine - pharmacology | Tetradecanoylphorbol Acetate - pharmacology | Foscarnet - pharmacology | Concanavalin A - pharmacology | Maleimides - pharmacology | Carbonates - pharmacology | Cytochalasin D - pharmacology | Tetradecanoylphorbol Acetate - antagonists & inhibitors | Sodium-Phosphate Cotransporter Proteins, Type IIa - metabolism | Dose-Response Relationship, Drug | LLC-PK1 Cells | Uranium - toxicity | Dexamethasone - pharmacology | Swine | Computer Simulation | Indoles - pharmacology | Sodium-Phosphate Cotransporter Proteins, Type IIb - physiology | Phosphates - pharmacology | Cell Survival - drug effects | Kidney Tubules, Proximal - cytology | Cadmium - toxicity | Phosphates - physiology | Meglumine - analogs & derivatives | Calcium Chloride - pharmacology | Animals | Meglumine - pharmacology | Uranium Compounds | Phosphates - antagonists & inhibitors | Kidney Tubules, Proximal - metabolism | Kidney Tubules, Proximal - drug effects
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2017, Volume 61, Issue 4
In any drug discovery and development effort, a reduction in the time of the lead optimization cycle is critical to decrease the time to license and reduce... 
Cutaneous leishmaniasis | BALB/c mouse | In vivo drug screen | Leishmania lesion cure | Mouse models | Leishmania lesion suppression | In vivo imaging system | Golden Syrian hamster | Antileishmanial drugs | Bioluminescence signal | Transgenic leishmania major | mouse models | VITRO | CELL-DEVELOPMENT | MICROBIOLOGY | MESOCRICETUS-AURATUS | cutaneous leishmaniasis | in vivo drug screen | in vivo imaging system | EXPERIMENTAL-MODELS | bioluminescence signal | transgenic Leishmania major | MILTEFOSINE | VIANNIA BRAZILIENSIS | PHARMACOLOGY & PHARMACY | antileishmanial drugs | INFECTION | FLUORESCENT PROTEIN | VISCERAL LEISHMANIASIS | FLUCONAZOLE | Optical Imaging | Fluconazole - pharmacology | Drug Evaluation, Preclinical - economics | Luciferases - metabolism | Leishmania major - genetics | Luminescent Measurements | Luciferases - genetics | Ofloxacin - pharmacology | Leishmania major - growth & development | Mesocricetus | Female | Organisms, Genetically Modified | Genes, Reporter | Cell Line | Cell Survival - drug effects | Drug Evaluation, Preclinical - methods | Leishmania major - drug effects | Amphotericin B - pharmacology | Leishmaniasis, Cutaneous - pathology | Leishmaniasis, Cutaneous - drug therapy | Macrophages - cytology | Antiprotozoal Agents - pharmacology | Triazoles - pharmacology | Animals | High-Throughput Screening Assays | Meglumine - pharmacology | Leishmaniasis, Cutaneous - parasitology | Macrophages - drug effects | Firefly Luciferin - administration & dosage | Mice | Mice, Inbred BALB C | Organometallic Compounds - pharmacology
Journal Article
Journal Article
Food and Chemical Toxicology, ISSN 0278-6915, 10/2013, Volume 60, pp. 360 - 368
Journal Article
Journal Article
Journal Article